Land: Irland
Språk: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Darunavir
Rowex Ltd
J05AE; J05AE10
Darunavir
800 milligram(s)
Film-coated tablet
Product subject to prescription which may not be renewed (A)
Protease inhibitors; darunavir
Marketed
2017-06-02
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT DARUNAVIR ROWEX 800 MG FILM-COATED TABLETS darunavir READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Darunavir Rowex is and what it is used for 2. What you need to know before you take Darunavir Rowex 3. How to take Darunavir Rowex 4. Possible side effects 5. How to store Darunavir Rowex 6. Contents of the pack and other information 1. WHAT DARUNAVIR ROWEX IS AND WHAT IT IS USED FOR WHAT IS DARUNAVIR ROWEX? Darunavir Rowex contains the active substance darunavir. Darunavir Rowex is an antiretroviral medicine used in the treatment of Human Immunodeficiency Virus (HIV) infection. It belongs to a group of medicines called protease inhibitors. Darunavir Rowex works by reducing the amount of HIV in your body. This will improve your immune system and reduces the risk of developing illnesses linked to HIV infection. WHAT IS IT USED FOR? Darunavir Rowex is used to treat adults and children (3 years of age and above, at least 40 kilograms body weight) - who are infected by HIV and who have not used antiretroviral medicines before - in certain patients who have used antiretroviral medicines before (your doctor will determine this). Darunavir Rowex must be taken in combination with a low dose of cobicistat or ritonavir and other anti-HIV medicines. Your doctor will discuss with you which combination of medicines is best for you. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DARUNAVIR ROWEX DO NOT TAKE DARUNAVIR ROWEX - if you are ALLERGIC to darunavir o read_full_document
HealthProductsRegulatoryAuthority 22June2023 CRN00DFH5 Page1of37 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT DarunavirRowex800mgFilm-coatedtablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Eachfilm-coatedtabletcontains800mgofdarunavir. Forthefulllistofexcipients,seesection6.1. 3 PHARMACEUTICAL FORM Film-coatedtablet Darkredovalshapedfilm-coatedtablet,debossedwith‘800’ononesideandplainontheotherside. Dimensions:approximately20.2x10.1mm 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Darunavir Rowex, co-administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal productsforthetreatmentofpatientswithhumanimmunodeficiencyvirus(HIV-1)infection. Darunavir Rowex, co-administered with cobicistat is indicated in combination with other antiretroviral medicinal products for thetreatmentofhumanimmunodeficiencyvirus(HIV-1)infectioninadultpatientsandadolescents(aged12yearsandolder, weighingatleast40kg)(seesection4.2). Darunavir Rowex tablets may be used to provide suitable dose regimens for the treatment of HIV-1 infection in adult and paediatricpatientsfromtheageof3yearsandatleast40kgbodyweightwhoare: antiretroviraltherapy(ART)-naïve(seesection4.2). ART-experiencedwithnodarunavirresistanceassociatedmutations(DRV-RAMs)andwhohaveplasmaHIV-1RNA <100,000copies/mlandCD4+cellcount≥100cellsx106/l.IndecidingtoinitiatetreatmentwithDarunavir RowexinsuchART-experiencedpatients, read_full_document